CClinicalTrials.gg
CompletedNCT07713394Updated Jul 20, 2026

The Effects of Intermittent Fasting on Anthropometric Measurements and Metabolic Parameters in Prediabetic Patients

An interventional study of Intermittent fasting and Caloric restriction in Prediabetes, Intermittent Fasting and Weight, sponsored by Ataturk University. Completed at 1 site in Turkey (Türkiye). Open to female participants aged 18 Years to 55 Years. Per ClinicalTrials.gov, last updated 2026-07-20.

Sponsored by Ataturk University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 3 years 6 months after the study started (first participant enrolled Jan 2023, registered Jul 2026).
Phase
Not applicable
Study type
Interventional
Enrollment
36
Allocation
Randomized
Ages
18 Years to 55 Years
Sex
Female
01

Study summary

The goal of this randomized controlled trial is to learn about the short-term effects of an 8-hour time-restricted eating (TRE) protocol combined with caloric restriction in women aged 18-55 years with prediabetes.

The main question it aims to answer is:

Does an 8-hour time-restricted eating protocol combined with caloric restriction improve anthropometric measurements and metabolic parameters more than caloric restriction alone in women with prediabetes?

Researchers will compare the time-restricted eating (IF) group to a control group following a conventional calorie-restricted diet with no time restriction, to see whether time-restricted eating provides additional benefit beyond that of caloric deficit alone.

Participants will:

Be randomly assigned to either the IF group (all meals consumed within an 8-hour window, 16-hour daily fast) or the control group (calorie-restricted diet, no time restriction), both matched for a 500 kcal/day energy deficit Follow their assigned diet for 5 weeks, with daily dietary reminders and support Undergo assessments at baseline and at the end of the 5-week intervention, including body weight, BMI, waist/hip circumference, body composition (bioimpedance), and fasting blood tests (glucose, insulin, HbA1c, total cholesterol, HDL-C, LDL-C, triglycerides)

02

Conditions studied

  • Prediabetes
  • Intermittent Fasting
  • Weight
03

In context

Prediabetic State

999 studies on the registry are indexed under Prediabetic State; 238 are open to participants now.

This study's enrollment of 36 is below the median of 65 across 844 interventional studies indexed under Prediabetic State.

Browse Prediabetic State studies →

Lead sponsor

Ataturk University is the lead sponsor of 442 studies on the registry; 121 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 55 Years
Sexes eligible
Female
Accepts healthy volunteers
No

Inclusion criteria

  • Female sex
  • Age between 18 and 55 years
  • Diagnosis of prediabetes (fasting plasma glucose 100-125 mg/dL and/or HbA1c 5.7%-6.4%)
  • Willingness and ability to attend in-person dietitian counseling at the Family Health Center Unit and to use WhatsApp for daily follow-up and reporting Provision of written informed consent

Exclusion criteria

Exclusion Criteria:

  • Pregnancy or lactation
  • Use of antidiabetic or immunosuppressive medications
  • Presence of endocrine disorders
  • History of malignancy or organ transplantation
  • Prior bariatric surgery
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
36 participants (actual)

Study arms

  • Experimental
    Intermittent Fasting (IF)

    Participants in the IF group followed a time-restricted eating schedule, consuming all meals within an 8-hour window (10:00 AM-6:00 PM), with a fasting period of 16 hours daily. To facilitate adherence and minimize side effects, the fasting duration was gradually increased over the first 6 days (12 hours for Days 1-3, 14 hours for Days 4-6), then maintained at 16 hours for the remaining 4 weeks. Diets were customized to individual energy needs and divided into 2-3 meals during the feeding window. Participants received daily reminders and support via WhatsApp, and were encouraged to report their food intake and physical activity.

    Behavioral: Intermittent fasting

  • Active comparator
    Control Group (CG)

    The CG participants followed a conventional hypocaloric diet with no time restriction. Their meals were distributed over 5-6 eating occasions throughout the day, spaced at 3-3.5 hour intervals. Diet content matched that of the IF group in terms of energy deficit and macronutrient composition. Participants received daily follow-up and education similar to the IF group.

    Behavioral: Caloric restriction

Interventions

  • BehavioralIntermittent fasting

    Eating in a specific hours of days, and being fast on remain of the day.

  • BehavioralCaloric restriction

    The participants followed a conventional hypocaloric diet with no time restriction. Their meals were distributed over 5-6 eating occasions throughout the day, spaced at 3-3.5 hour intervals

06

What researchers measure

Primary outcomes

  1. weight

    weight and height will be combined to report BMI in kg/m\^2

    Time frame: 5 weeks

Secondary outcomes

  1. Waist circumference (WC)

    Waist circumference will be measured in centimeters using a non-stretch tape measure. Waist circumference measured in centimeters using a non-stretch tape measure.

    Time frame: 5 weeks

  2. lipid parameters

    After 12 hours fasting, total cholesterol, HDL-C, LDL-C, triglycerides measured in mg. Also TG/HDL-C ratio calculated.

    Time frame: 5 weeks

07

Study locations

1 site
  • Ataturk University
    Erzurum, Turkey 25040, Turkey (Türkiye)
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 20, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07713394
Lead sponsor
Ataturk University
Responsible party
Yasemin Cayir (Prof. Dr., Ataturk University) — Principal investigator
First posted
Jul 20, 2026
Start date
Jan 1, 2023
Primary completion
Dec 31, 2023
Completion
Dec 31, 2023
Last update
Jul 20, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion